NEW YORK (GenomeWeb News) – Advion BioSciences today announced that it has signed a definitive agreement to sell its BioServices division to Quintiles Transnational for an undisclosed amount of cash.
Advion BioServices is a bioanalytical lab offering pharmacokinetic/pharmacodynamics testing and other services. The sale will allow Advion to focus on its core systems and consumables business.